Reimagining medicine to transform prostate cancer treatment
Prostate cancer is the second most common form of cancer in people with the prostate gland worldwide. Risk for the disease increases with age, for Black men, and for those who have a family history.
Symptoms can vary, and some people do not experience any symptoms, therefore screening is important. The standard screening procedure is a PSA blood test, which measures the prostate-specific antigen protein in the blood. If the PSA is elevated, a biopsy may be required.
What is prostate cancer?
Cancer is a disease in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems.
When cancer starts in the prostate, it is called prostate cancer. The prostate is a small, walnut-shaped gland, located just below the bladder and in front of the rectum, and part of the male reproductive system. The prostate gland surrounds the urethra (the tube that empties urine from the bladder) and produces fluid that makes up part of semen.
What are prostate cancer survival rates?
Prostate cancer can either be localized (there is no sign that the cancer has spread outside the prostate), regional (the cancer has spread outside the prostate to nearby structures or lymph nodes), or advanced (the cancer has spread to parts of the body farther from the prostate).
We are collaborating with patient organizations to raise awareness about prostate cancer.
The organizations below can help you find your nearest support groups and societies:
Resources for patients:
Websites are listed for informational purposes only; this information is not intended to be an endorsement or recommendation of any organization.